Psychotropic DrugsSilvio Garattini, V. Ghetti Elsevier Publishing Company, 1957 - 606 sider |
Inni boken
Resultat 1-3 av 71
Side 35
... Mental Diseases , 122 ( 1955 ) 463 . 14 H. C. B. DENBER AND S. MERLIS , Psychiat . Quart . , 29 ( 1955 ) 421 . 15 ... Mental Diseases , 124 ( 1956 ) 74 . 18 H. C. B. DENBER ( in preparation ) . 19 H. C. B. DENBER , Discussion , Regional ...
... Mental Diseases , 122 ( 1955 ) 463 . 14 H. C. B. DENBER AND S. MERLIS , Psychiat . Quart . , 29 ( 1955 ) 421 . 15 ... Mental Diseases , 124 ( 1956 ) 74 . 18 H. C. B. DENBER ( in preparation ) . 19 H. C. B. DENBER , Discussion , Regional ...
Side 40
... mental changes in man . ( c ) Psychic effects . The pattern of psychic changes in man resembles that pro- voked by mescaline , although about 5000 times as much of the latter substance is needed . A characteristic feature of the psychic ...
... mental changes in man . ( c ) Psychic effects . The pattern of psychic changes in man resembles that pro- voked by mescaline , although about 5000 times as much of the latter substance is needed . A characteristic feature of the psychic ...
Side 567
... Mental Sci . , 102 ( 1956 ) 30 . 12 E. FISCHER , J. Mental Sci . , 102 ( 1956 ) 542 . 13 A. FOLKSON AND A. R. MAY , Brit . Med . J. , ii , ( 1955 ) 1121 . 14 E. D. FREIS , New Engl . J. Med . , 251 ( 1954 ) 1005 . 15 E. H. HARE , C. P. ...
... Mental Sci . , 102 ( 1956 ) 30 . 12 E. FISCHER , J. Mental Sci . , 102 ( 1956 ) 542 . 13 A. FOLKSON AND A. R. MAY , Brit . Med . J. , ii , ( 1955 ) 1121 . 14 E. D. FREIS , New Engl . J. Med . , 251 ( 1954 ) 1005 . 15 E. H. HARE , C. P. ...
Innhold
Metabolism of mediator substances | 3 |
Adrenochrome and adrenolutin and their relationship to mental disease | 10 |
Some relationships between tranquilization indolalkylamines and brain structure | 21 |
Opphavsrett | |
51 andre deler vises ikke
Vanlige uttrykk og setninger
acid action activité activity administration agents amines animals appear Arch avons behavior blocking blood brain cause central changes chlorpromazine clinical compared compounds cortex d'une decrease depression derivatives doses drogues drug effect electrical été evidence excitation experimental experiments Exptl fact findings formation forme function given important increase indicate inhibition injection intern Italy l'action l'activité less measures mechanism mental meprobamate mescaline mg/kg midbrain minutes nervous system Neurol normal nous observed obtained occur patients pattern period peut Pharmacol Physiol possible present produced produits promazine Psychiat Psychol reaction recorded reflex reported reserpine response reticular seems serotonin shock showed shown similar souris stimulation studies subjects substances symptoms syndrome TABLE technique therapy tion tissue treatment tubocurarine various